Patents by Inventor Juan Carlos Morales Sanchez

Juan Carlos Morales Sanchez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Silylated derivatives of resveratrol and the use thereof in neurodegenerative, neurological or inflammatory diseases
    Patent number: 11365208
    Abstract: The present invention relates to a group of compounds derived from resveratrol having as substituents at least one silyl group which, in turn, can be substituted by different groups. The invention also relates to the therapeutic use of these compounds in inflammatory, neurological, and neurodegenerative diseases.
    Type: Grant
    Filed: November 23, 2017
    Date of Patent: June 21, 2022
    Assignee: Consejo Superior De Investigaciones Cientificas
    Inventors: Juan Carlos Morales Sánchez, Pablo Peñalver Puente, Efres Belmonte Reche, Elena González Rey, Maria Luisa Mateos Martin
  • ACYLATED COMPOUNDS FOR THE TREATMENT OF OCULAR PATHOLOGIES
    Publication number: 20220079965
    Abstract: A therapeutic use of acylated piceid derivative compounds in ocular pathologies, in particular retinitis pigmentosa and in age-related macular degeneration, inter alia. A method of treating and/or preventing ocular pathologies, wherein the method includes administering to a patient in need of treatment a therapeutically effective amount of a compound of general formula (I) or any of its isomers, their pharmaceutically acceptable salts, esters, tautomers, polymorphs, or hydrates.
    Type: Application
    Filed: November 30, 2021
    Publication date: March 17, 2022
    Inventors: Juan Carlos MORALES SÁNCHEZ, Pablo PEÑALVER PUENTE, Francisco Javier DÍAZ CORRALES, María Lourdes VALDÉS SÁNCHEZ, Ana Belén GARCÍA DELGADO, Adoración MONTERO SÁNCHEZ
  • Acylated compounds for the treatment of ocular pathologies
    Patent number: 11213536
    Abstract: The present invention relates to the therapeutic use of acylated piceid derivative compounds in ocular pathologies, in particular retinitis pigmentosa and in age-related macular degeneration.
    Type: Grant
    Filed: November 17, 2017
    Date of Patent: January 4, 2022
    Assignees: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS, FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD
    Inventors: Juan Carlos Morales Sánchez, Pablo Peñalver Puente, Francisco Javier Díaz Corrales, María Lourdes Valdés Sánchez, Ana Belén García Delgado, Adoración Montero Sánchez
  • SILYLATED DERIVATIVES OF RESERVATROL AND THE USE THEREOF IN NEURODEGENERATIVE, NEUROLOGICAL OR INFLAMMATORY DISEASES
    Publication number: 20190284213
    Abstract: The present invention relates to a group of compounds derived from resveratrol having as substituents at least one silyl group which, in turn, can be substituted by different groups. The invention also relates to the therapeutic use of these compounds in inflammatory, neurological, and neurodegenerative diseases.
    Type: Application
    Filed: November 23, 2017
    Publication date: September 19, 2019
    Inventors: Juan Carlos Morales Sánchez, Pablo Peñalver Puente, Efres Belmonte Reche, Elena González Rey, María Luisa Mateos Martín
  • ACYLATED COMPOUNDS FOR THE TREATMENT OF OCULAR PATHOLOGIES
    Publication number: 20190275068
    Abstract: The present invention relates to the therapeutic use of acylated piceid derivative compounds in ocular pathologies, in particular retinitis pigmentosa and in age-related macular degeneration.
    Type: Application
    Filed: November 17, 2017
    Publication date: September 12, 2019
    Inventors: Juan Carlos MORALES SÁNCHEZ, Pablo PEÑALVER PUENTE, Francisco Javier DÍAZ CORRALES, María Lourdes VALDÉS SÁNCHEZ, Ana Belén GARCÍA DELGADO, Adoración MONTERO SÁNCHEZ
  • COMPOUNDS HAVING ANTI-INFLAMMATORY ACTIVITY
    Publication number: 20120309699
    Abstract: Compounds of general formula (I) for the treatment of inflammatory processes involved in numerous diseases such as intestinal inflammatory diseases. The invention moreover refers to compounds included within such general formula and to the procedure of the obtainment thereof.
    Type: Application
    Filed: December 14, 2010
    Publication date: December 6, 2012
    Applicant: Consejo Superior de Investigaciones Cientificas (CSIC)
    Inventors: Juan Carlos Espin De Gea, Juan Carlos Morales Sánchez, Isabel Medina Mendez
  • Natural compounds and their derivatives for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications
    Patent number: 7098246
    Abstract: The present invention refers to the use of phenolic compounds and their derivatives represented by formula I wherein R1 and R2 are selected from among: OH, OCOalkyl, or OCOalkenyl, and R3 is either H, OH, OCOalkyl or OCOalkenyl, wherein the alkyl or alkenyl chains present from 2 to 22 carbon atoms and wherein at least one OCOalkyl or OCOalkenyl group is present in the structure, for the prevention and treatment of cardiovascular, hepatic or renal diseases, as well as to their cosmetic applications, to compositions that include these compounds and to some novel phenolic compounds and derivatives.
    Type: Grant
    Filed: April 3, 2003
    Date of Patent: August 29, 2006
    Assignee: Puleva Biotech, S.A.
    Inventors: Arjan Geelings, Eduardo Lopez-Huertas Leon, Juan Carlos Morales Sanchez, Julio Boza Puerta, Jesús Jimenez Lopez
  • Natural products and derivatives thereof for protection against neurodegenerative diseases
    Publication number: 20030236202
    Abstract: The invention relates to the use of phenolic compounds and derivatives thereof for protection against neurodegenerative diseases, to compositions comprising these compounds, and to some novel phenolic compounds.
    Type: Application
    Filed: April 3, 2003
    Publication date: December 25, 2003
    Inventors: Arjan Geelings, Eduardo Lopez-Huertas Leon, Juan Carlos Morales Sanchez, Julio Boza Puerta, Jesus Jimenez Lopez
  • Natural compounds and their derivatives for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications
    Publication number: 20030225160
    Abstract: The present invention refers to the use of phenolic compounds and their derivatives represented by formula I wherein R1 and R2 are selected from among: OH, OCOalkyl, or OCOalkenyl, and R3 is either H, OH, OCOalkyl or OCOalkenyl, wherein the alkyl or alkenyl chains present from 2 to 22 carbon atoms and wherein at least one OCOalkyl or OCOalkenyl group is present in the structure, for the prevention and treatment of cardiovascular, hepatic or renal diseases, as well as to their cosmetic applications, to compositions that include these compounds and to some novel phenolic compounds and derivatives.
    Type: Application
    Filed: April 3, 2003
    Publication date: December 4, 2003
    Inventors: Arjan Geerlings, Eduardo Lopez-Huertas Leon, Juan Carlos Morales Sanchez, Julio Boza Puerta, Jesus Jimenez Lopez